$980,327
+28.9%
Board Member (End 08/24); Interim President RSF Foundation (Beg 10/24)
2024
$902k related
49.5 hrs/wk
$79k other
--
Board Member (End 08/24); Interim President RSF Foundation (Beg 10/24) at Clinical Biotechnology Research Institute at RSFH
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Megan Baker, M.D. has been listed as an employee of Clinical Biotechnology Research Institute at RSFH in Form 990 filings since fiscal year 2023. Total compensation for Megan Baker, M.D. has increased by 28.9% from 2023 to 2024.